Makcef T 250mg/31.25mg Injection
Marketer
Makcur Laboratories Ltd.
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Makcef T 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg) is a dual-action antibiotic used to combat a range of bacterial infections. Its mechanism involves inhibiting bacterial growth and halting infection progression. Administration must be strictly under medical guidance. Complete the prescribed dosage; premature cessation can compromise efficacy. Regular appointments are crucial. Typical mild side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms immediately to your physician. Seek urgent medical attention for allergic responses such as skin rashes, itching, swelling, or breathing difficulties. Inform your doctor about all current medications, including over-the-counter drugs, before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally safe for driving, refrain from operating machinery if drowsiness or dizziness occur. Adequate rest, proper nutrition, and hydration contribute to faster recovery. Your doctor may order blood tests or other investigations to monitor the treatment's effect.
Uses of Makcef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Makcef T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Makcef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Makcef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Makcef T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Makcef T 250mg/31.25mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Makcef T 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
Ceftazidime/Sulbactam 250mg/31.25mg injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
The injection Makcef T (250mg/31.25mg) requires careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Makcef T 250mg/31.25mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Operation of a vehicle should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Makcef T 250mg/31.25mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable formulation of Makcef T (250mg/31.25mg) requires careful administration in individuals with advanced hepatic impairment. Dosage modification of this injection may be necessary. Physician consultation is advised. Altering the dose of Makcef T (250mg/31.25mg) injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Makcef T 250mg/31.25mg Injection :
Omitting a scheduled dose of Makcef T 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Makcef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently